Cargando…

Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis

Fuzheng-Huayu (FZHY) formula has been found to have a satisfactory effect on hepatitis B-caused cirrhosis (HBC) treatment. However, the efficacy evaluation of FZHY is often challenging. In this study, a randomized, double-blind and placebo-controlled trial was used to evaluate the therapeutic effica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qilong, Wu, Feizhen, Wang, Mei, Dong, Shu, Liu, Yamin, Lu, Yiyu, Song, Yanan, Zhou, Qianmei, Liu, Ping, Luo, Yunquan, Su, Shibing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926417/ https://www.ncbi.nlm.nih.gov/pubmed/27271613 http://dx.doi.org/10.3390/ijms17060883

Ejemplares similares

MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis
por: Liu, Yamin, et al.
Publicado: (2017)

Antiliver Fibrosis Formula of Fuzheng Huayu Alleviates Inflammatory Response
por: Chang, Qing-Qi, et al.
Publicado: (2022)

Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis
por: Chen, Qi-Long, et al.
Publicado: (2015)

Author Correction: MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis
por: Liu, Yamin, et al.
Publicado: (2020)

Effect of Fuzheng Huayu formula and its actions against liver fibrosis
por: Liu, Chenghai, et al.
Publicado: (2009)

Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis
por: Dong, Shu, et al.
Publicado: (2015)

Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis
por: Shi, Ke, et al.
Publicado: (2020)

Proteomic Analysis of the Effect of Fuzheng Huayu Recipe on Fibrotic Liver in Rats
por: Xie, Hongdong, et al.
Publicado: (2013)

Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I–induced kidney fibrosis through network pharmacology
por: Wang, Fan, et al.
Publicado: (2022)

Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats
por: Yang, Tao, et al.
Publicado: (2019)

Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice
por: Jia, Yan-Hong, et al.
Publicado: (2012)

Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis
por: Wu, Rong, et al.
Publicado: (2019)

A Randomized Controlled Study of Fuzheng Huayu Capsule for Prevention of Esophageal Variceal Bleeding in Patients with Liver Cirrhosis
por: Gu, Jie, et al.
Publicado: (2013)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial
por: Hassanein, Tarek, et al.
Publicado: (2022)

Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism
por: Li, Qing-Ya, et al.
Publicado: (2013)

Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis
por: Tao, Yan-yan, et al.
Publicado: (2014)

The components data of fuzheng huayu extracts, cordyceps sinensis mycelia polysaccharide, gypenosides and amygdalin
por: Liu, Wei, et al.
Publicado: (2019)

Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice
por: Jiang, Chunyan, et al.
Publicado: (2020)

The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability – A Network Pharmacology and Transcriptomics Approach
por: Xing, Xinrui, et al.
Publicado: (2018)

In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa
por: Xu, Hongri, et al.
Publicado: (2020)

Effect of Fuzheng Huayu capsule combined with Pegasys on genotype 1 hepatitis C fibrosis and cell apoptosis
por: ZHANG, BO, et al.
Publicado: (2014)

Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet
por: Dai, Yun-Kai, et al.
Publicado: (2023)

Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis
por: Gui, Hong-Lian, et al.
Publicado: (2020)

Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis: A Multicenter Double-Blind Randomized Controlled Trail
por: Song, Ya-Nan, et al.
Publicado: (2013)

Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe
por: Ping, Da-bing, et al.
Publicado: (2023)

Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells
por: Pan, Qin, et al.
Publicado: (2015)

Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes
por: Xing, Lu, et al.
Publicado: (2022)

Simultaneous determination of eight analytes of Fuzheng Huayu recipe in beagle dog plasma by UHPLC–Q/exactive Orbitrap HRMS and its application to toxicokinetics
por: Wang, Yu‐Lin, et al.
Publicado: (2022)

Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2023)

Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells
por: Zhou, Qianmei, et al.
Publicado: (2015)

Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice
por: Wang, Rong-Qi, et al.
Publicado: (2015)

Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkers
por: Lu, Yiyu, et al.
Publicado: (2019)

Fuzheng Huayu Recipe Prevented and Treated CCl4-Induced Mice Liver Fibrosis through Regulating Polarization and Chemotaxis of Intrahepatic Macrophages via CCL2 and CX3CL1
por: Zhang, Man, et al.
Publicado: (2020)

Fuzheng Yiliu Formula Regulates Tumor Invasion and Metastasis through Inhibition of WAVE3 Expression
por: Chen, Wen-li, et al.
Publicado: (2021)

Renoprotective Effect of Yiqi Yangyin Huayu Tongluo Formula against Diabetic Nephropathy in Diabetic Rats
por: Wang, Feng-li, et al.
Publicado: (2018)

The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice
por: Wang, Feixue, et al.
Publicado: (2018)

Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the RASSF1A Gene
por: Huang, Yajing, et al.
Publicado: (2020)

Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
por: Wang, Zihao, et al.
Publicado: (2019)

Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial
por: Chen, Yangyi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_458h8lf05ja2rdrg8eqlv302rs